Article Text

other Versions

Download PDFPDF
Changes to UK BCG vaccination schedules with implications for women on biologic medications during pregnancy
  1. Matthew Parsons1,
  2. Rachel Cooney2
  1. 1Obstetrics Department, Birmingham Women's and Children's NHS Foundation Trust, Birmingham, UK
  2. 2GI Unit, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK
  1. Correspondence to Dr Rachel Cooney, GI Unit, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK; rachel.cooney{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Bacillus Calmette-Guerin (BCG) vaccine is a live attenuated vaccine. With declining incidence of Tuberculosis in Europe, the only countries that routinely administer BCG to all babies at birth are Ireland, Bosnia–Herzegovina, Portugal and Norway.

In the UK, BCG is given to selected groups and there has been a recent change nationally in the timing of BCG vaccination. The timing of BCG has been moved from birth to 4 weeks to facilitate a pilot into severe combined immunodeficiency screening in six areas of the UK (Manchester, Birmingham, Sheffield, Newcastle, London Great Ormond Street Hospital and London Southeast Thames).1

The British Society of Gastroenterology recommend that babies exposed to biologics …

View Full Text


  • Twitter @rachelcooney7

  • Contributors RC conceived and wrote the first draft of letter and MP revised it.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.